Summary & Overview
HCPCS S5550: Insulin, Rapid-Onset, 5 Units
HCPCS Level II code S5550 denotes a 5-unit dose of rapid-onset insulin used for short-term glucose control. As a supply/drug administration code, it identifies small, discrete insulin doses provided in ambulatory and clinic settings and can affect billing for diabetes management across multiple payers. Nationally, accurate coding for insulin doses influences claims adjudication, patient cost-sharing, and inventory reporting for outpatient services.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, the clinical contexts in which a 5-unit rapid-onset insulin dose is used, and how the code functions within service lines for outpatient medication administration. The publication summarizes payer coverage presence, common modifiers associated with HCPCS drug and supply reporting, and typical sites of service where S5550 is billed.
This analysis provides practical benchmarks for coding and billing clarity, highlights policy and coverage considerations relevant to national payers, and situates S5550 within clinical workflows for diabetes care. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S5550 describes insulin, rapid onset, 5 units. This entry represents a small-dose administration of a rapid-acting insulin preparation intended for glycemic control.
-
Service type: Drug administration and supply of a rapid-onset insulin dose
-
Typical site of service: Outpatient clinic, physician office, infusion center, or other ambulatory care settings where injectable medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with type 1 or type 2 diabetes who requires a small, clinic-administered dose of rapid‑acting insulin for acute hyperglycemia or peri‑procedural glycemic control. The patient arrives to an outpatient infusion clinic, endocrinology office, emergency department, or ambulatory surgery center with blood glucose above target (for example, >250 mg/dL) or in anticipation of a procedure that requires short‑term insulin coverage. The clinician verifies identity, reviews recent blood glucose and medication history, obtains point‑of‑care glucose, calculates the required 5‑unit rapid‑acting insulin dose based on institutional sliding scale or individualized orders, documents informed consent, and administers the injection subcutaneously. Post‑administration monitoring includes repeat glucose checks at 15–60 minutes, assessment for hypoglycemia symptoms, and documentation of dose, lot number, and site. Typical sites of service include outpatient clinics, emergency departments, ambulatory surgery centers, and skilled nursing facilities.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier applies to the service |
22 |